Talphera (TLPH) Shares Outstanding (2010 - 2026)
Talphera's (TLPH) quarterly Shares Outstanding (Entity) came in at $34.5 million in Q2 2025, up 31.79% year-on-year from $26.2 million in Q2 2024, and up 31.45% quarter-over-quarter from $26.3 million in Q1 2025.
Talphera (TLPH) Shares Outstanding (2010 - 2026) Analysis & Trends
Talphera's Shares Outstanding (Entity) history runs 15 years deep, the most recent figure standing at $34.5 million for Q2 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 31.79% year-over-year to $34.5 million in Q2 2025; TTM through Jun 2025 was $34.5 million, a 31.79% increase from a year earlier, with the FY2024 full-year figure at $25.8 million, up 52.46% from the prior year.
- Shares Outstanding (Entity) climbed to $34.5 million in Q2 2025 per TLPH's latest filing, from $26.3 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $34.5 million in Q2 2025 and bottomed at $6.0 million in Q1 2021.
- The 5-year median for Shares Outstanding (Entity) is $11.0 million (2023), against an average of $15.3 million.
- Across the five-year window, Shares Outstanding (Entity) jumped 138.32% in 2024 and grew 6.25% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $6.8 million in 2021, then grew by 20.5% to $8.2 million in 2022, then soared by 105.64% to $17.0 million in 2023, then soared by 52.46% to $25.8 million in 2024, then surged by 33.6% to $34.5 million in 2025.
- Per Business Quant, the three latest TLPH Shares Outstanding (Entity) figures stand at $34.5 million (Q2 2025), $26.3 million (Q1 2025), and $25.8 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 69.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.82 Mn |
| Dec 31, 2025 | 42.41 Mn |
| Sep 30, 2025 | 41.45 Mn |
| Jun 30, 2025 | 34.53 Mn |
| Mar 31, 2025 | 26.27 Mn |
| Dec 31, 2024 | 25.85 Mn |
| Sep 30, 2024 | 26.21 Mn |
| Jun 30, 2024 | 26.20 Mn |
| Mar 31, 2024 | 24.72 Mn |
| Dec 31, 2023 | 14.26 Mn |
| Sep 30, 2023 | 16.76 Mn |
| Jun 30, 2023 | 10.92 Mn |
| Mar 31, 2023 | 10.89 Mn |
| Dec 31, 2022 | 7.39 Mn |
| Sep 30, 2022 | 7.38 Mn |
| Jun 30, 2022 | 7.36 Mn |
| Mar 31, 2022 | 7.28 Mn |
| Dec 31, 2021 | 5.99 Mn |
| Sep 30, 2021 | 5.96 Mn |
| Jun 30, 2021 | 5.96 Mn |